Endothelial endocytic pathways: Gates for vascular drug delivery

Current Vascular Pharmacology

Volumn 2, Issue 3, 2004, Pages 281-299

  Muro, Silvia ^a   Koval, Michael ^b   Muzykantov, Vladimir ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Drug delivery; Endocytosis; Intracellular trafficking; Paracellular transport; Transcytosis; Vascular endothelium

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMANTADINE; AMMONIUM CHLORIDE; BAFILOMYCIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CHLOROQUINE; CHLORPROMAZINE; CYTOCHALASIN; DANSYLCADAVERINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FILIPIN; GENISTEIN; GLYCOPROTEIN; GLYCOPROTEIN GP 60; GLYCOPROTEIN GP 85; GLYCOPROTEIN GP 90; INTERCELLULAR ADHESION MOLECULE 1; LATRUNCULIN A; LIPOSOME; MONENSIN; NOCODAZOLE; PADGEM PROTEIN; POLYMER; RADICICOL; STAUROSPORINE; THROMBOMODULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; WORTMANNIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD VESSEL WALL; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL ORGANELLE; DRUG BINDING SITE; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR TRANSPORT; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; TRANSCYTOSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 3042696866     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161043385736     Document Type: Review

References (301)

1. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91(10): 3527- 61.
2. Gimbrone MA, Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol 1999; 155(1): 1-5.
3. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264(9): 4743-6.
4. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84(7): 2068-101.
5. Muller WA. Leukocyte- endothelial cell interactions in the inflammatory response. Lab Invest 2002; 82(5): 521-33.
6. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346(6283): 425-34.
7. Bevilacqua MP, Nelson RM. Endothelial-leukocyte adhesion molecules in inflammation and metastasis. Thromb Haemost 1993; 70(1): 152-4.
8. Ley K, Tedder TF. Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J Immunol 1995; 155(2): 525-8.
9. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 1996; 98(8): 1699-702.
10. Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest 2001; 107(1): 23-5.
11. Zulueta JJ, Sawhney R, Yu FS, Cote CC, Hassoun PM. Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am J Physiol 1997; 272(5 Pt 1): L897-902.
12. Rubbo H, Tarpey M, Freeman BA. Nitric oxide and reactive oxygen species in vascular injury. Biochem Soc Symp 1995; 61: 33-45.
13. Kennel SJ, Lee R, Bultman S, Kabalka G. Rat monoclonal antibody distribution in mice: an epitope, inside the lung vascular space mediates very efficient localization. Int J Rad Appl Instrum B 1990; 17(2): 193-200.
14. Danilov SM, Muzykantov VR, Martynov AV, Atochina EN, Sakharov I, Trakht IN, et al. Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme. Lab Invest 1991; 64(1): 118-24.
15. Jacobson BS, Schnitzer JE, McCaffery M, Palade GE. Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs. Eur J Cell Biol 1992; 58(2): 296-306.
16. Keelan ET, Harrison AA, Chapman PT, Binns RM, Peters AM, Haskard DO. Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med 1994; 35(2): 276-81.
17. Muzykantov VR, Danilov SM. Targeting of radiolabeled monoclonal antibody against ACE to the pulmonary endothelium. In: V. Torchilin, editor. Targeted Delivery of Imaging Agents. Roca Baton, Florida: CRC Press; 1995; p. 465-485.
18. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1997; 275(5299): 547-50.
19. Schnitzer JE. Vascular targeting as a strategy for cancer therapy. N Engl J Med 1998; 339(7): 472-4.
20. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998; 102(2): 430-7.
21. Stan RV, Ghitescu L, Jacobson BS, Palade GE. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 1999; 145(6): 1189-98.
22. Li S, Tan Y, Viroonchatapan E, Pitt BR, Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000; 278(3): L504-11.
23. Nicklin SA, White SJ, Watkins SJ, Hawkins RE, Baker AH. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation 2000; 102(2): 231-7.
24. Ranney DF. Biomimetic transport and rational drug delivery. Biochem Pharmacol 2000; 59(2): 105-14.
25. Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, et al. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther 2000; 2(6): 562-78.
26. Reynolds PN, Nicklin SA, Kaliberova L, Boatman BG, Grizzle WE, Balyasnikova IV, et al. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol 2001; 19(9): 838-42.
27. Poznansky MJ, Juliano RL. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 1984; 36(4): 277-336.
28. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31(1): 51-60.
29. Semple G, Ashworth DM, Batt AR, Baxter AJ, Benzies DW, Elliot LH, et al. Peptidomimetic aminomethylene ketone inhibitors of interleukin-1 beta-converting enzyme (ICE). Bioorg Med Chem Lett 1998; 8(8): 959-64.
30. Bangham AD. Surrogate cells or Trojan horses. The discovery of liposomes. Bioessays 1995; 17(12): 1081-8.
31. Tamada JA, Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 1993; 90(2): 552-6.
32. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997; 388(6645): 860-2.
33. Bartus RT, Tracy MA, Emerich DF, Zale SE. Sustained delivery of proteins for novel therapeutic agents. Science 1998; 281(5380): 1161-2.
34. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18(1): 33-7.
35. Shen ZR, Zhu JH, Ma Z, Wang F, Wang ZY. Preparation of biodegradable microspheres of testosterone with poly(D,L-lactide-co-glycolide) and test of drug release in vitro. Artif Cells Blood Substit Immobil Biotechnol 2000; 28(1): 57-64.
36. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22(3): 231-41.
37. Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001; 48(2-3): 229-47.
38. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977; 252(11): 3582-6.
39. Phillips WT, Klipper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski V, et al. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J Pharmacol Exp Ther 1999; 288(2): 665-70.
40. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989; 256(2 Pt 2): H589-93.
41. Freeman BA, Turrens JF, Mirza Z, Crapo JD, Young SL. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 1985; 44(10): 2591-5.
42. Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther 2000; 292(3): 1048-52.
43. Adlakha-Hutcheon G, Bally MB, Shew CR, Madden TD. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol 1999; 17(8): 775-9.
44. Raso V. Immunotargeting intracellular compartments. Anal Biochem 1994; 222(2): 297-304.
45. Caron PC, Laird W, Co MS, Avdalovic NM, Queen C, Scheinberg DA. Engineered humanized dimeric forms of IgG are more effective antibodies. J Exp Med 1992; 176(4): 1191-5.
46. Pardridge WM, Buciak J, Yang J, Wu D. Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. J Pharmacol Exp Ther 1998; 286(1): 548-54.
47. Becerril B, Poul MA, Marks JD. Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun 1999; 255(2): 386-93.
48. Nielsen UB, Marks JD. Internalizing antibodies and targeted cancer therapy: direct selection from phage display libraries. Pharm Sci Technol 2000; 3(8): 282-291.
49. Schwartz JJ, Zhang S. Peptide-mediated cellular delivery. Curr Opin Mol Ther 2000; 2(2): 162-7.
50. Jin LH, Bahn JH, Eum WS, Kwon HY, Jang SH, Han KH, et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med 2001; 31(11): 1509-19.
51. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18(4): 410-4.
52. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 2001; 98(15): 8786-91.
53. Muzykantov V. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology 1998; 5: 15-33.
54. Greenwalt TJ, Steane EA. Evaluation of methods for quantitating erythrocyte antibodies and description of a new method using horseradish peroxidase-labelled antiglobulin. Haematologia (Budap) 1980; 13(1-4): 33-48.
55. Vainio O, Dunon D, Aissi F, Dangy JP, McNagny KM, Imhof BA. HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors. J Cell Biol 1996; 135(6 Pt 1): 1655-68.
56. Goetz DJ, el-Sabban ME, Hammer DA, Pauli BU. Lu-ECAM-1-mediated adhesion of melanoma cells to endothelium under conditions of flow. Int J Cancer 1996; 65(2): 192-9.
57. McIntosh DP, Tan XY, Oh P, Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 2002; 99(4): 1996-2001.
58. Kennel SJ, Lankford TK, Foote LJ, Davis IA, Boll RA, Mirzadeh S. Combination vascular targeted and tumor targeted radioimmunotherapy. Cancer Biother Radiopharm 1999; 14(5): 371-9.
59. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. Faseb J 1995; 9(10): 946-55.
60. Christofidou-Solomidou M, Kennel S, Scherpereel A, Wiewrodt R, Solomides CC, Pietra GG, et al. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration. Am J Pathol 2002; 160(3): 1155-69.
61. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990; 16(4): 363-70.
62. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95(3): 588-93.
63. Heitsch H, Brovkovych S, Malinski T, Wiemer G. Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells. Hypertension 2001; 37(1): 72-76.
64. Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, et al. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001; 280(6): L1335-47.
65. Muzykantov VR, Atochina EN, Kuo A, Barnathan ES, Notarfrancesco K, Shuman H, et al. Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme. Am J Physiol 1996; 270(5 Pt 1): L704-13.
66. Olson SC, Dowds TA, Pino PA, Barry MT, Burke-Wolin T. ANG II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. Am J Physiol 1997; 273(2 Pt 1): L315-21.
67. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, et al. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J Biol Chem 1994; 269(43): 26806-14.
68. Sadhukhan R, Santhamma KR, Reddy P, Peschon JJ, Black RA, Sen I. Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice. J Biol Chem 1999; 274(15): 10511-6.
69. Balyasnikova IV, Karran EH, Albrecht RF 2nd, Danilov SM. Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface. Biochem J 2002; 362(Pt 3): 585-95.
70. Muzykantov VR. Delivery of antioxidant enzyme proteins to the lung. Antioxid Redox Signal 2001; 3(1): 39-62.
71. Atochina EN, Hiemisch HH, Muzykantov VR, Danilov SM. Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme. Lung 1992; 170(6): 349-58.
72. Muzykantov VR, Atochina EN, Ischiropoulos H, Danilov SM, Fisher AB. Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc Natl Acad Sci USA 1996; 93(11): 5213-8.
73. Atochina EN, Balyasnikova IV, Danilov SM, Granger DN, Fisher AB, Muzykantov VR. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol 1998; 275(4 Pt 1): L806-17.
74. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99(1): 3-8.
75. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, Harshaw DW, Schultz L, Fisher AB, et al. Streptavidin facilitates internalization and pulmonary targeting of an anti- endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 1999; 96(5): 2379-84.
76. Rinaldo J, Christman, J. ARDS: pathogenesis. In: Fishman A, editor. Fishman's Pulmonary Diseases and Disorders. New York: McGraw and Hill; 1998. p. 2537-2548.
77. Mulligan MS, Miyasaka M, Tamatani T, Jones ML, Ward PA. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol 1994; 152(2): 832-40.
78. Meyrick BO. Endotoxin-mediated pulmonary endothelial cell injury. Fed Proc 1986; 45(1): 19-24.
79. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren, II, Thom SR, Jones ML, et al. Involvement of platelet- endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993; 262(5139): 1580-2.
80. Scherpereel A, Wiewrodt R, Christofidou-Solomidou M, Gervais R, Murciano JC, Albelda SM, et al. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J 2001; 15(2): 416-26.
81. Scherpereel A, Rome JJ, Wiewrodt R, Watkins SC, Harshaw DW, Alder S, et al. Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther 2002; 300(3): 777-86.
82. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243(4895): 1160-5.
83. Albelda SM. Endothelial and epithelial cell adhesion molecules. Am J Respir Cell Mol Biol 1991; 4(3): 195-203.
84. Kishimoto TK, Rothlein R. Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv Pharmacol 1994; 25: 117-69.
85. Panes J, Perry MA, Anderson DC, Muzykantov VR, Carden DL, Miyasaka M, et al. Portal hypertension enhances endotoxin-induced intercellular adhesion molecule 1 up-regulation in the rat. Gastroenterology 1996; 110(3): 866-74.
86. Komatsu S, Panes J, Russell JM, Anderson DC, Muzykantov VR, Miyasaka M, et al. Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo. Hypertension 1997; 29(2): 683-9.
87. Murciano JC, Muro S, Koniaris L, Christofidou-Solomidou M, Harshaw DW, Albelda SM, et al. ICAM-directed vascular immunotargeting of anti-thrombotic agents to the endothelial surface. Blood 2003; 101(10): 3977-84.
88. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137(1): 245-54.
89. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 2000; 28(9): 1379-86.
90. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993; 142(6): 1739-49.
91. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, Jones ML, et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 1996; 157(10): 4609-14.
92. Amano J, Hiroe M, Ohta Y, Ishiyama S, Nishikawa T, Tanaka H, et al. Uptake of indium-111-anti-intercellular adhesion molecule-1 monoclonal antibody in the allografted rat lung during acute rejection. J Heart Lung Transplant 1996; 15(10): 1027-33.
93. Sasso DE, Gionfriddo MA, Thrall RS, Syrbu SI, Smilowitz HM, Weiner RE. Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 1996; 37(4): 656-61.
94. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998; 98(1): 1-5.
95. Weiner RE, Sasso DE, Gionfriddo MA, Syrbu SI, Smilowitz HM, Vento J, et al. Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 1998; 39(4): 723-8.
96. Klibanov AL, Hughes MS, Villanueva FS, Jankowski RJ, Wagner WR, Wojdyla JK, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. Magma 1999; 8(3): 177-84.
97. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65(6): 961-71.
98. Kunkel EJ, Jung U, Bullard DC, Norman KE, Wolitzky BA, Vestweber D, et al. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J Exp Med 1996; 183(1): 57-65.
99. Steeber DA, Campbell MA, Basit A, Ley K, Tedder TF. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci USA 1998; 95(13): 7562-7.
100. Jun CD, Shimaoka M, Carman CV, Takagi J, Springer TA. Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion. Proc Natl Acad Sci USA 2001; 98(12): 6830-5.
101. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56(5): 849-53.
102. Rothlein R, Mainolfi EA, Kishimoto TK. Treatment of inflammation with anti-ICAM-1. Res Immunol 1993; 144(9): 735-9; discussion 754-62.
103. DeMeester SR, Molinari MA, Shiraishi T, Okabayashi K, Manchester JK, Wick MR, et al. Attenuation of rat lung isograft reperfusion injury with a combination of anti-ICAM-1 and anti-beta2 integrin monoclonal antibodies. Transplantation 1996; 62(10): 1477-85.
104. Lefer DJ, Flynn DM, Anderson DC, Buda AJ. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am J Physiol 1996; 271(6 Pt 2): H2421-9.
105. Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 1996; 156(9): 3550-7.
106. Kumasaka T, Quinlan WM, Doyle NA, Condon TP, Sligh J, Takei F, et al. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest 1996; 97(10): 2362-9.
107. Ghitescu L, Jacobson BS, Crine P. A novel, 85 kDa endothelial antigen differentiates plasma membrane macrodomains in lung alveolar capillaries. Endothelium 1999; 6(3): 241-50.
108. Murciano JC, Harshaw DW, Ghitescu L, Danilov SM, Muzykantov VR. Vascular immunotargeting to endothelial surface in a specific macrodomain in alveolar capillaries. Am J Respir Crit Care Med 2001; 164(7): 1295-302.
109. Muller WA, Steinman RM, Cohn ZA. The membrane proteins of the vacuolar system. II. Bidirectional flow between secondary lysosomes and plasma membrane. J Cell Biol 1980; 86(1): 304-14.
110. Song BW, Vinters HV, Wu D, Pardridge WM. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J Pharmacol Exp Ther 2002; 301(2): 605-10.
111. Zhang Y, Schlachetzki F, Pardridge WM. Global non-viral gene transfer to the primate brain following intravenous administration. Mol Ther 2003; 7(1): 11-9.
112. von Asmuth EJ, Smeets EF, Ginsel LA, Onderwater JJ, Leeuwenberg JF, Buurman WA. Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol 1992; 22(10): 2519-26.
113. Kuijpers TW, Raleigh M, Kavanagh T, Janssen H, Calafat J, Roos D, et al. Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process. J Immunol 1994; 152(10): 5060-9.
114. Kiely JM, Cybulsky MI, Luscinskas FW, Gimbrone MA, Jr. Immunoselective targeting of an anti-thrombin agent to the surface of cytokine-activated vascular endothelial cells. Arterioscler Thromb Vasc Biol 1995; 15(8): 1211-8.
115. Spragg DD, Alford DR, Greferath R, Larsen CE, Lee KD, Gurtner GC, et al. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci USA 1997; 94(16): 8795-800.
116. Fujise K, Revelle BM, Stacy L, Madison EL, Yeh ET, Willerson JT, et al. A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. Circulation 1997; 95(3): 715-22.
117. Harari OA, Wickham TJ, Stocker CJ, Kovesdi I, Segal DM, Huehns TY, et al. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Ther 1999; 6(5): 801-7.
118. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001; 104(17): 2107-12.
119. McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, et al. Tumor therapy with targeted atomic nanogenerators. Science 2001; 294(5546): 1537-40.
120. Folkman J. Angiogenesis inhibitors generated by tumors. Mol Med 1995; 1(2): 120-2.
121. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 2001; 46(1-3): 149-68.
122. Dvorak HF, Nagy JA, Dvorak AM. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991; 3(3): 77-85.
123. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156(4): 1363-80.
124. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264(5158): 569-71.
125. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995; 1(12): 1623-34.
126. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al. Genes expressed in human tumor endothelium. Science 2000; 289(5482): 1197-202.
127. Molema G. Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies. Pharm Res 2002; 19(9): 1251-8.
128. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998; 279(5349): 377-80.
129. Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe PE. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res 1998; 58(20): 4646-53.
130. Duncan R. Polymer-drug conjugates: targeting cancer. In: Muzykantov V and Torchilin V, editors. Biomedical aspects of drug targeting. Boston/Dodrecht/London.: Kluwer Academic Publishers; 2003; p. 193-209.
131. Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, et al. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Cancer Res 2000; 60(24): 6942-9.
132. Schraa AJ, Kok RJ, Berendsen AD, Moorlag HE, Bos EJ, Meijer DK, et al. Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting. J Control Release 2002; 83(2): 241-51.
133. Riezman H, Woodman PG, van Meer G, Marsh M. Molecular mechanisms of endocytosis. Cell 1997; 91(6): 731-8.
134. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422(6927): 37-44.
135. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997; 77(3): 759-803.
136. Simionescu M, Gafencu A, Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 2002; 57(5): 269-88.
137. Rippe B, Rosengren BI, Carlsson O, Venturoli D. Transendothelial transport: the vesicle controversy. J Vasc Res 2002; 39(5): 375-90.
138. Simionescu M, Simionescu N. Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev 1991; 25(1): 5-78.
139. Predescu D, Palade GE. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol 1993; 265(2 Pt 2): H725-33.
140. Minshall RD, Tiruppathi C, Vogel SM, Malik AB. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 2002; 117(2): 105-12.
141. Stan RV. Structure and function of endothelial caveolae. Microsc Res Tech 2002; 57(5): 350-64.
142. Schnitzer JE, Liu J, Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995; 270(24): 14399-404.
143. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995; 269(5229): 1435-9.
144. Schnitzer JE. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001; 49(3): 265-80.
145. Montesano R, Roth J, Robert A, Orci L. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 1982; 296(5858): 651-3.
146. Tran D, Carpentier JL, Sawano F, Gorden P, Orci L. Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci USA 1987; 84(22): 7957-61.
147. Parton RG, Joggerst B, Simons K. Regulated internalization of caveolae. J Cell Biol 1994; 127(5): 1199-215.
148. Vilhardt F, Nielsen M, Sandvig K, van Deurs B. Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. Mol Biol Cell 1999; 10(1): 179-95.
149. Raub TJ, Audus KL. Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers. J Cell Sci 1990; 97 (Pt 1): 127-38.
150. Teasdale MS, Bird CH, Bird P. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain. Immunol Cell Biol 1994; 72(6): 480-8.
151. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255(5043): 410-1.
152. Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr Eye Res 2000; 21(2): 637-45.
153. Kosugi I, Muro H, Shirasawa H, Ito I. Endocytosis of soluble IgG immune complex and its transport, to lysosomes in hepatic sinusoidal endothelial cells. J Hepatol 1992; 16(1-2): 106-14.
154. Stang E, Kindberg GM, Berg T, Roos N. Endocytosis mediated by the mannose receptor in liver endothelial cells. An immunocytochemical study. Eur J Cell Biol 1990; 52(1): 67-76.
155. Dini L, Kolb-Bachofen V. Preclustered receptor arrangement is a prerequisite for galactose-specific clearance of large particulate ligands in rat liver. Exp Cell Res 1989; 184(1): 235-40.
156. Kempka G, Kolb-Bachofen V. Binding, uptake, and transcytosis of ligands for mannose-specific receptors in rat liver: an electron microscopic study. Exp Cell Res 1988; 176(1): 38-48.
157. Geoffroy JS, Becker RP. Endocytosis by endothelial phagocytes: uptake of bovine serum albumin-gold conjugates in bone marrow. J Ultrastruct Res 1984; 89(3): 223-39.
158. Volker W, Schon P, Vischer P. Binding and endocytosis of thrombospondin and thrombospondin fragments in endothelial cell cultures analyzed by cuprolinic blue staining, colloidal gold labeling, and silver enhancement techniques. J Histochem Cytochem, 1991; 39(10): 1385-94.
159. Yoshioka T, Yamamoto K, Kobashi H, Tomita M, Tsuji T. Receptor-mediated endocytosis of chemically modified albumins by sinusoidal endothelial cells and Kupffer cells in rat and human liver. Liver 1994; 14(3): 129-37.
160. Smedsrod B, Malmgren M, Ericsson J, Laurent TC. Morphological studies on endocytosis of chondroitin sulphate proteoglycan by rat liver EC. Cell Tissue Res 1988; 253(1): 39-45.
161. Pitas RE, Boyles J, Mahley RW, Bissell DM. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific EC. J Cell Biol 1985; 100(1): 103-17.
162. Stitt AW, Anderson HR, Gardiner TA, Bailie JR, Archer DB. Receptor-mediated endocytosis and intracellular trafficking of insulin and low-density lipoprotein by retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 1994; 35(9): 3384-92.
163. Roberts RL, Fine RE, Sandra A. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci 1993; 104 (Pt 2): 521-32.
164. Roberts RL, Sandra A. Transport of transferrin across the blood-thymus barrier in young rats. Tissue Cell 1994; 26(5): 757-66.
165. Stins MF, Maxfield FR, Goldberg IJ. Polarized binding of lipoprotein lipase to endothelial cells. Implications for its physiological actions. Arterioscler Thromb 1992; 12(12): 1437-46.
166. Stein O, Halperin G, Leitersdorf E, Olivecrona T, Stein Y. Lipoprotein lipase mediated uptake of non-degradable ether analogues of phosphatidylcholine and cholesteryl ester by cultured cells. Biochim Biophys Acta 1984; 795(1): 47-59.
167. Goti D, Balazs Z, Panzenboeck U, Hrzenjak A, Reicher H, Wagner E, et al. Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alphatocopherol in a porcine in vitro blood-brain barrier model. J Biol Chem 2002; 277(32): 28537-44.
168. Stins MF, Sivaram P, Sasaki A, Goldberg IJ. Specificity of lipoprotein lipase binding to endothelial cells. J Lipid Res 1993; 34(11): 1853-61.
169. Schonherr E, Zhao B, Hausser H, Muller M, Langer C, Wagner
170. Zimmermann R, Panzenbock U, Wintersperger A, Levak-Frank S, Graier W, Glatter O, et al. Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. Diabetes 2001; 50(7): 1643-53.
171. Schnitzer JE, Shen CP, Palade GE. Lectin analysis of common glycoproteins detected on the surface of continuous microvascular endothelium in situ and in culture: identification of sialoglycoproteins. Eur J Cell Biol 1990; 52(2): 241-51.
172. Kounnas MZ, Chappell DA, Strickland DK, Argraves WS. Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro. J Biol Chem 1993; 268(19): 14176-81.
173. Le Panse S, Galceran M, Pontillon F, Lelongt B, van de Putte M, Ronco PM, et al. Immunofunctional properties of a yolk sac epithelial cell line expressing two proteins gp280 and gp330 of the intermicrovillar area of proximal tubule cells: inhibition of endocytosis by the specific antibodies. Eur J Cell Biol 1995; 67(2): 120-9.
174. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, Iozzo RV, et al. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invest 1997; 100(6): 1611-22.
175. Straley KS, Green SA. Rapid transport of internalized P-selectin to late endosomes and the TGN: roles in regulating cell surface expression and recycling to secretory granules. J Cell Biol 2000; 151(1): 107-16.
176. Kessner S, Krause A, Rothe U, Bendas G. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human EC. Biochim Biophys Acta 2001; 1514(2): 177-90.
177. Everts M, Kok RJ, Asgeirsdottir SA, Melgert BN, Moolenaar TJ, Koning GA, et al. Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate. J Immunol 2002; 168(2): 883-9.
178. Stossel TP. The early history of phagocytosis. In: Tartakoff AM, editor. In Advances in cell and molecular biology of membranes and organelles. Stamford. Connecticut: JAI Press Inc.; 1999; p. 3-18.
179. Caron E, Hall A. Phagocytosis: Oxford University Press; 2001.
180. Koval M, Preiter K, Adles C, Stahl PD, Steinberg TH. Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res 1998; 242(1): 265-73.
181. Hall A. Phagocytosis. In: Marsh M, editor. Endocytosis. Oxford. UK: Oxford University Press; 2001; p. 58-77.
182. Griffin FM Jr, Griffin JA, Leider JE, Silverstein SC. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J Exp Med 1975; 142(5): 1263-82.
183. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, Kita T, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in EC. Proc Natl Acad Sci USA 1998; 95(16): 9535-40.
184. Eugene E, Hoffmann I, Pujol C, Couraud PO, Bourdoulous S, Nassif X. Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci 2002; 115(Pt 6): 1231-41.
185. Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol 1995; 5: 424-81.
186. Lewis. Pinocytosis. Johns Hopkins Hosp Bull 1931; 49: 17-36.
187. Machesky LM, Reeves E, Wientjes F, Mattheyse FJ, Grogan A, Totty NF, et al. Mammalian actin-related protein 2/3 complex localizes to regions of lamellipodial protrusion and is composed of evolutionarily conserved proteins. Biochem J 1997; 328 (Pt 1): 105-12.
188. Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC, et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. Proc Natl Acad Sci USA 1999; 96(7): 3739-44.
189. Saito T, Lamy F, Roger PP, Lecocq R, Dumont JE. Characterization and identification as cofilin and destrin of two thyrotropin- and phorbol ester-regulated phosphoproteins in thyroid cells. Exp Cell Res 1994; 212(1): 49-61.
190. Veithen A, Cupers P, Baudhuin P, Courtoy PJ. v-Src induces constitutive macropinocytosis in rat fibroblasts. J Cell Sci 1996; 109 (Pt 8): 2005-12.
191. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70(3): 389-99.
192. Bar-Sagi D, Feramisco JR. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 1986; 233(4768): 1061-8.
193. Swanson JA. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J Cell Sci 1999; 94 (Pt 1): 135-42.
194. Wennstrom S, Siegbahn A, Yokote K, Arvidsson AK, Heldin CH, Mori S, et al. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene 1994; 9(2): 651-60.
195. Willingham MC, Haigler HT, Fitzgerald DJ, Gallo MG, Rutherford AV, Pastan IH. The morphologic pathway of binding and internalization of epidermal growth factor in cultured cells. Studies on A431, KB, and 3T3 cells, using multiple methods of labelling. Exp Cell Res 1983; 146(1): 163-75.
196. Mellstrom K, Heldin CH, Westermark B. Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. Exp Cell Res 1988; 177(2): 347-59.
197. Brunk U, Schellens J, Westermark B. Influence of epidermal growth factor (EGF) on ruffling activity, pinocytosis and proliferation of cultivated human glia cells. Exp Cell Res 1976; 103(2): 295-302.
198. Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 2002; 76(13): 6689-700.
199. Gil J. Number and distribution of plasmalemmal vesicles in the lung. Fed Proc 1983; 42(8): 2414-8.
200. Ghinea N, Mai TV, Groyer-Picard MT, Milgrom E. How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells. J Cell Biol 1994; 125(1): 87-97.
201. Roberts RL, Sandra A. Receptor-mediated endocytosis of insulin by cultured endothelial cells. Tissue Cell 1992; 24(5): 603-11.
202. Ring A, Pohl J, Volkl A, Stremmel W. Evidence for vesicles that mediate long-chain fatty acid uptake by human microvascular endothelial cells. J Lipid Res 2002; 43(12): 2095-104.
203. Conway EM, Nowakowski B, Steiner-Mosonyi M. Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis. J Cell Physiol 1994; 158(2): 285-98.
204. Conway EM, Boffa MC, Nowakowski B, Steiner-Mosonyi M. An ultrastructural study of thrombomodulin endocytosis: internalization occurs via clathrin-coated and non-coated pits. J Cell Physiol 1992; 151(3): 604-12.
205. Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SI, et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002; 99(3): 912-22.
206. Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR, et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 2003; 116(Pt 8): 1599-1609.
207. Behera AK, Matsuse H, Kumar M, Kong X, Lockey RF, Mohapatra SS. Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun 2001; 280(1): 188-95.
208. Schober D, Kronenberger P, Prchla E, Blaas D, Fuchs R. Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J Virol 1998; 72(2): 1354-64.
209. Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat Med 1997; 3(12): 1405-8.
210. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 2002; 418(6894): 200-3.
211. 2 and endothelial oxidative stress. Am J Physiol 1999; 277(2 Pt 1): L271-81.
212. Christofidou-Solomidou M, Pietra GG, Solomides CC, Arguiris E, Harshaw D, Fitzgerald GA, et al. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 2000; 278(4): L794-805.
213. Sweitzer TD, Thomas AP, Wiewrodt R, Nakada MT, Branco F, Muzykantov VR. Pecam-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide. Free Radic Biol Med 2003; 34(8): 1035-46.
214. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, Muro S, Buerk DG, Solomides CC, et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidant stressand reduces acute lung transplantation injury. Nat Biotechnol 2003; 21(4): 392-8.
215. Yajima Y, Kawashima S. Calpain function in the differentiation of mesenchymal stem cells. Biol Chem 2002; 383(5): 757-64.
216. Gil-Parrado S, Popp O, Knoch TA, Zahler S, Bestvater F, Felgentrager M, et al. Subcellular localization and in vivo subunit interactions of ubiquitous mu -calpain. J Biol Chem 2003; 278: 1636-46.
217. Gregoriou M, Willis AC, Pearson MA, Crawford C. The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem 1994; 223(2): 455-64.
218. Guttmann RP, Baker DL, Seifert KM, Cohen AS, Coulter DA, Lynch DR. Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem 2001; 78(5): 1083-93.
219. Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001; 86(1): 198-213.
220. Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA, et al. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997; 272(52): 32719-22.
221. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, Fiacco KA, et al. Calpain regulates actin remodeling during cell spreading. J Cell Biol 1998; 141(3): 647-62.
222. Dunlop RA, Rodgers KJ, Dean RT. Recent developments in the intracellular degradation of oxidized proteins. Free Radic Biol Med 2002; 33(7): 894-906.
223. Tanaka K, Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev 1998; 163: 161-76.
224. Groettrup M, Khan S, Schwarz K, Schmidtke G. Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 2001; 83(3-4): 367-72.
225. Gruenberg J. The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2001; 2(10): 721-30.
226. Stoorvogel W, Strous GJ, Geuze HJ, Oorschot V, Schwartz AL. Late endosomes derive from early endosomes by maturation. Cell 1991; 65(3): 417-27.
227. Reaves BJ, Banting G, Luzio JP. Lumenal and transmembrane domains play a role in sorting type I membrane proteins on endocytic pathways. Mol Biol Cell 1998; 9(5): 1107-22.
228. Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1996; 12: 575-625.
229. Knight A, Hughson E, Hopkins CR, Cutler DF. Membrane protein trafficking through the common apical endosome compartment of polarized Caco-2 cells. Mol Biol Cell 1995; 6(5): 597-610.
230. Fuchs R, Male P, Mellman I. Acidification and ion permeabilities of highly purified rat liver endosomes. J Biol Chem 1989; 264(4): 2212-20.
231. Mellman I. The importance of being acid: the role of acidification in intracellular membrane traffic. J Exp Biol 1992; 172: 39-45.
232. Warnock DG. Regulation of endosomal acidification via Gi-type protein. Kidney Int 1999; 55(6): 2524-5.
233. Gille L, Nohl H. The existence of a lysosomal redox chain and the role of ubiquinone. Arch Biochem Biophys 2000; 375(2): 347-54.
234. Killisch I, Steinlein P, Romisch K, Hollinshead R, Beug H, Griffiths G. Characterization of early and late endocytic compartments of the transferrin cycle. Transferrin receptor antibody blocks erythroid differentiation by trapping the receptor in the early endosome. J Cell Sci 1992; 103 (Pt 1): 211-32.
235. Futai M, Oka T, Moriyama Y, Wada Y. Diverse roles of single membrane organelles: factors establishing the acid lumenal pH. J Biochem (Tokyo) 1998; 124(2): 259-67.
236. Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol 1989; 5: 483-525.
237. Pillay CS, Elliott E, Dennison C. Endolysosomal proteolysis and its regulation. Biochem J 2002; 363(Pt 3): 417-29.
238. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 1991; 266(32): 21327-30.
239. Storer AC, Menard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol 1994; 244: 486-500
240. de Bruyn PP, Cho Y, Michelson S. In vivo endocytosis by bristle coated pits of protein tracers and their intracellular transport in the endothelial cells lining the sinuses of the liver. II. The endosomal-lysosomal transformation. J Ultrastruct Res 1983; 85(3): 290-9.
241. Sheff DR, Daro EA, Hull M, Mellman I. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J Cell Biol 1999; 145(1): 123-39.
242. Mellman IS, Plutner H, Steinman RM, Unkeless JC, Cohn ZA. Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis. J Cell Biol 1983; 96(3): 887-95.
243. Pitt A, Mayorga LS, Schwartz AL, Stahl PD. Transport of phagosomal components to an endosomal compartment. J Biol Chem 1992; 267(1): 126-32.
244. Mayorga LS, Bertini F, Stahl PD. Fusion of newly formed phagosomes with endosomes in intact cells and in a cell-free system. J Biol Chem 1991; 266(10): 6511-7.
245. Hewlett LJ, Prescott AR, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol 1994; 124(5): 689-703.
246. Desjardins M, Huber LA, Parton RG, Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol 1994; 124(5): 677-88.
247. Parton RG, Lindsay M. Exploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40. Immunol Rev 1999; 168: 23-31.
248. Norkin LC. Simian virus 40 infection via MHC class I molecules and caveolae. Immunol Rev 1999; 169: 13-22.
249. Kamen BA, Johnson CA, Wang MT, Anderson RG. Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation. J Clin Invest 1989; 84(5): 1379-86.
250. Haasemann M, Cartaud J, Muller-Esterl W, Dunia I. Agonist- induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 1998; 111 (Pt 7): 917-28.
251. Chun M, Liyanage UK, Lisanti MP, Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 1994; 91(24): 11728-32.
252. Dessy C, Kelly RA, Balligand JL, Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 2000; 19(16): 4272-80.
253. Muro S, Cui X, Gajewski C, Muzykantov VR, Koval M. Slow intracellular trafficking of catalase nanoparticles targeted to endothelial ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol Cell 2003; 285(5): 1339-47.
254. Bomsel M, Parton R, Kuznetsov SA, Schroer TA, Gruenberg J. Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 1990; 62(4): 719-31.
255. Palade GE, Simionescu M, Simionescu N. Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl 1979; 463: 11-32.
256. Majno G. Maude Abbott Lecture - 1991. The capillary then and now: an overview of capillary pathology. Mod Pathol 1992; 5(1): 9-22.
257. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 1999; 6(1): 7-22.
258. Schnitzer JE, Oh P, McIntosh DP. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 1996; 274(5285): 239-42.
259. Niles WD, Malik AB. Endocytosis and exocytosis events regulate vesicle traffic in EC. J Membr Biol 1999; 167(1): 85-101.
260. Minshall RD, Tiruppathi C, Vogel SM, Niles WD, Gilchrist A, Hamm HE, et al. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J Cell Biol 2000; 150(5): 1057-70.
261. Vogel SM, Easington CR, Minshall RD, Niles WD, Tiruppathi C, Hollenberg SM, et al. Evidence of transcellular permeability pathway in microvessels. Microvasc Res 2001; 61(1): 87-101.
262. Volker W, Hess S, Vischer P, Preissner KT. Binding and processing of multimeric vitronectin by vascular endothelial cells. J Histochem Cytochem 1993; 41(12): 1823-32.
263. John TA, Vogel SM, Tiruppathi C, Malik AB, Minshall RD. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 2003; 284(1): L187-96.
264. Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 2001; 49(4): 419-32.
265. Simionescu N, Siminoescu M, Palade GE. Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels. J Cell Biol 1975; 64(3): 586-607.
266. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994; 127(5): 1217-32.
267. Predescu D, Predescu S, McQuistan T, Palade GE. Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium. Proc Natl Acad Sci USA 1998; 95(11): 6175-80.
268. Horvat R, Palade GE. Thrombomodulin and thrombin localization on the vascular endothelium; their internalization and transcytosis by plasmalemmal vesicles. Eur J Cell Biol 1993; 61(2): 299-313.
269. Vasile E, Simionescu M, Simionescu N. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 1983; 96(6): 1677-89.
270. Robinson CS, Wagner RC. Differential endocytosis of lipoproteins by capillary endothelial vesicles. Microcirc Endothelium Lymphatics 1985; 2(3): 313-29.
271. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 1997; 272(41): 25968-75.
272. Predescu D, Predescu S, Malik AB. Transport of nitrated albumin across continuous vascular endothelium. Proc Natl Acad Sci USA 2002; 99(21): 13932-7.
273. Terasaki T, Pardridge WM. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). J Drug Target 2000; 8(6): 353-5.
274. Prokai-Tatrai K, Nguyen V, Zharikova AD, Braddy AC, Stevens SM, Prokai L. Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH(2). Bioorg Med Chem Lett 2003; 13(6): 1011-4.
275. Stins MF, Nemani PV, Wass C, Kim KS. Escherichia coli binding to and invasion of brain microvascular endothelial cell derived from humans and rats of different ages. Infect Immun 1999; 67(10): 5522-5.
276. Muruganandam A, Tanha J, Narang S, Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J 2002; 16(2): 240-2
277. Wengenack TM, Curran GL, Olson EE, Poduslo JF. Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood-nerve and blood-brain barriers. Brain Res 1997; 767(1): 128-35.
278. Scherphof GL, Romero EL, Velinova MJ, Kamps JAAM, Koning GA, Meijer DKF, Swart P, Daemen T, editor. Endothelial and transendothelial delivery of pharmaceutically active agents; potential of liposomes. Leiden. The Netherlands.: Kupffer Cell Foundation; 1999.
279. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2(4): 285-93.
280. Fanning AS, Mitic LL, Anderson JM. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999; 10(6): 1337-45.
281. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161(3): 653-60.
282. Hopkins AM, Li D, Mrsny RJ, Walsh SV, Nusrat A. Modulation of tight junction function by G protein-coupled events. Adv Drug Deliv Rev 2000; 41(3): 329-40.
283. Nourry C, Grant SG, Borg JP. PDZ domain proteins: plug and play! Sci STKE 2003; 2003(179): RE7.
284. Pawson T, Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003; 300(5618): 445-52.
285. Martin TA, Mansel RE, Jiang WG. Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol 2002; 192(3): 268-75.
286. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 2000; 279(3): L419-22.
287. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267(3 Pt 1): L223-41.
288. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 1999; 6(1): 7-22.
289. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156(4): 1363-80.
290. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998; 95(8): 4607-12.
291. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 1999; 6(1): 23-44.
292. Haselton FR, Alexander JS, Mueller SN. Adenosine decreases permeability of in vitro endothelial monolayers. J Appl Physiol 1993; 74(4): 1581-90.
293. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1996; 98(9): 1949-53.
294. Moore TM, Norwood NR, Creighton JR, Babal P, Brough GH, Shasby DM, et al. Receptor-dependent activation of store-operated calcium entry increases endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2000; 279(4): L691-8.
295. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267(3 Pt 1): L223-41.
296. Verin AD, Csortos C, Durbin SD, Aydanyan A, Wang P, Patterson CE, et al. Characterization of the protein phosphatase 1 catalytic subunit in endothelium: involvement in contractile responses. J Cell Biochem 2000; 79(1): 113-25.
297. Cho MM, Ziats NP, Pal D, Utian WH, Gorodeski GI. Estrogen modulates paracellular permeability of human endothelial cells by cNOS- and iNOS-related mechanisms. Am J Physiol 1999; 276(2 Pt 1): C337-49.
298. Wu J, Akaike T, Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res 1998; 58(1): 159-65.
299. Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001; 74(1-3): 47-61.
300. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice. Science 2000; 293: 2449-2452.
301. Schlegel A, Pestell RG, Lisanti MP. Caveolins in cholesterol trafficking and signal transduction: implications for human disease. Front Biosci 2000; 5: D929-37.